This provided a hypothesis that the high-risk OV cancers highly expressed CD276 to enhance glycolysis, which directly stimulated the amino acid metabolism of fibroblast or acidated the microenvironment to prompt fibroblast metabolism. The gene discussed is CD276; the disease is cancer.